Page results
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
UCLH Charity’s magazine, Charity Matters is out now.
-
This leaflet explains the Catheter Directed Thrombolysis (CDT) procedure at UCLH.
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
The autumn/winter edition of Charity Matters is out now.
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
Dr Matthew Adams is a consultant radiologist with a special interest in stroke, movement disorders and neurogenetics.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
At UCLH, we are extremely proud of our staff and their dedication to delivering the best care for our patients. If you have been treated or looked after by an exceptional member of staff, or a volunteer, we would love you to tell us about it.
File results
-
FOI/2022/0360 - Staff contact details in charge of catering, vending and beverages
-
FOI/2022/0364 - Onsite incinerator
-
FOI/2022/0365 - Job roles at Trust with net zero in title
-
FOI/2022/0367 - Coagulation testing
-
FOI/2022/0368 - Recruitment data
-
FOI/2022/0369 - Inpatient mental health facilities
-
FOI/2022/0371 - Patients presented at A&E with dental health problems
-
FOI/2022/0372 - Number of offences relating to sexual misconduct
-
FOI/2022/0373 - Policy for patients with orthopaedic injuries sustained whilst staying away from home
-
FOI/2022/0377 - Usage of Dabrafenib + Trametinib in cancer treatment